FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

12948411000001105: Nobligan retard 100mg tablets (Grunenthal Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
45657801000001114 Nobligan retard 100mg tablets (Grunenthal Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
45657901000001115 Nobligan retard 100mg tablets (Grunenthal Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nobligan retard 100mg tablets (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register Exempt Safe Custody) true Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Is a Tramadol hydrochloride 100mg m/r tablet false Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Has active ingredient Tramadol hydrochloride true Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Is a Nobligan true Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Has specific active ingredient Tramadol hydrochloride true Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Is a Tramadol 100mg modified-release tablets false Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) Is a Tramadol 100mg modified-release tablets true Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Nobligan retard 100mg tablets (Grunenthal Ltd) 60 tablet 6 x 10 tablets Is pack of False Nobligan retard 100mg tablets (Grunenthal Ltd) Inferred relationship Existential restriction modifier
Nobligan retard 100mg tablets (Grunenthal Ltd) 60 tablet 6 x 10 tablets Has AMP True Nobligan retard 100mg tablets (Grunenthal Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start